Proficio Capital Partners LLC Invests $1.97 Million in UnitedHealth Group Incorporated $UNH

Key Points

• Proficio Capital Partners initiated a $1.97 million position in UnitedHealth Group during the second quarter by purchasing 4,748 shares. Institutional investors collectively own 87.86% of the company.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and an average price target of $456.56. Recent targets were raised by Morgan Stanley, RBC, and Truist Financial.
• UnitedHealth reported quarterly earnings of $6.38 per share, exceeding estimates, on $112.03 billion in revenue. The company also declared a quarterly dividend of $2.32 per share, equivalent to a 2.4% annual yield.

Proficio Capital Partners LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 4,748 shares of the healthcare conglomerate's stock, valued at approximately $1,973,000.

Several other institutional investors have also modified their holdings of UNH. Brighton Jones LLC raised its stake in shares of UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after acquiring an additional 28,231 shares during the period. Revolve Wealth Partners LLC grew its holdings in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after purchasing an additional 2,324 shares during the last quarter. CMT Capital Markets Trading GmbH purchased a new stake in UnitedHealth Group in the 2nd quarter worth about $340,000. Flow Traders U.S. LLC bought a new position in shares of UnitedHealth Group during the second quarter valued at approximately $356,000. Finally, Jump Financial LLC purchased a new stake in shares of UnitedHealth Group in the second quarter worth approximately $377,000. 87.86% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on UNH shares. Wall Street Zen upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Saturday, August 8th. Royal Bank Of Canada boosted their price objective on shares of UnitedHealth Group from $463.00 to $478.00 and gave the company an "outperform" rating in a research report on Friday, July 17th. Morgan Stanley raised their target price on shares of UnitedHealth Group from $468.00 to $529.00 and gave the stock an "overweight" rating in a research report on Friday, July 17th. Sanford C. Bernstein reiterated an "outperform" rating on shares of UnitedHealth Group in a report on Tuesday, July 21st. Finally, Truist Financial lifted their price target on UnitedHealth Group from $440.00 to $480.00 and gave the company a "buy" rating in a report on Tuesday, July 14th. Two analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and six have assigned a Hold rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $456.56.

UnitedHealth Group Trading Down 0.8%

Shares of UnitedHealth Group stock opened at $389.92 on Tuesday. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a 12-month low of $255.96 and a 12-month high of $461.62. The firm has a market capitalization of $349.99 billion, a price-to-earnings ratio of 25.09, a PEG ratio of 1.36 and a beta of 0.62. The firm's 50 day simple moving average is $412.95 and its two-hundred day simple moving average is $361.54.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, beating the consensus estimate of $4.94 by $1.44. The company had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The firm's revenue was up .4% on a year-over-year basis. During the same period in the prior year, the company earned $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Analysts predict that UnitedHealth Group Incorporated will post 19.82 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be paid a $2.32 dividend. The ex-dividend date of this dividend is Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.4%. UnitedHealth Group's payout ratio is currently 59.72%.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 1,169 shares of the stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares in the company, valued at approximately $5,977,920. This represents a 7.09% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.19% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source